Avience Biomedicals (NSE:AVIENCE) Total Assets: ₹660.7 Mil (As of Jan. 2026)


NSE:AVIENCE Avience Biomedicals Ltd NSE:AVIENCE
5 GF Score
Price ₹414.95
View Full Analysis

What is Avience Biomedicals Total Assets?

Avience Biomedicals NSE:AVIENCE 5 Total Assets is ₹660.7 Mil as of Jan. 2026. GuruFocus rates NSE:AVIENCE with a GF Score™ of 5/100.

Avience Biomedicals's Total Assets for the quarter that ended in Jan. 2026 was ₹660.7 Mil.

Total Assets is connected with ROA %. Avience Biomedicals's annualized ROA % for the quarter that ended in Jan. 2026 was 0.00%. Total Assets is also linked to Revenue through Asset Turnover. Avience Biomedicals's Asset Turnover for the quarter that ended in Jan. 2026 was 0.00.

Avience Biomedicals  (NSE:AVIENCE) Total Assets Explanation

Total Assets is connected with ROA %.

Avience Biomedicals's annualized ROA % for the quarter that ended in Jan. 2026 is

ROA %=Net Income (Q: Jan. 2026 )/( (Total Assets (Q: Mar. 2025 )+Total Assets (Q: Jan. 2026 ))/ count )
=0/( (565.246+660.72)/ 2 )
=0/612.983
=0.00 %

Note: The Net Income data used here is four times the quarterly (Jan. 2026) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Avience Biomedicals's Asset Turnover for the quarter that ended in Jan. 2026 is

Asset Turnover
=Revenue (Q: Jan. 2026 )/( (Total Assets (Q: Mar. 2025 )+Total Assets (Q: Jan. 2026 ))/ count )
=0/( (565.246+660.72)/ 2 )
=0/612.983
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Avience Biomedicals Total Assets Related Terms

Avience Biomedicals Total Assets Historical Data

* Premium members only.

The historical data trend for Avience Biomedicals's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avience Biomedicals Total Assets Chart

Avience Biomedicals Annual Data
Trend Mar23 Mar24 Mar25
Total Assets
100.21 346.51 565.25

Avience Biomedicals Quarterly Data
Mar23 Mar24 Mar25 Jan26
Total Assets 100.21 346.51 565.25 660.72
NSE:AVIENCE
5GF Score
Avience Biomedicals Ltd NSE:AVIENCE
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Avience Biomedicals Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Avience Biomedicals's Total Assets for the fiscal year that ended in Mar. 2025 is calculated as

Total Assets=Total Equity (A: Mar. 2025 )+Total Liabilities (A: Mar. 2025 )
=227.771+337.475
=565.2

Avience Biomedicals's Total Assets for the quarter that ended in Jan. 2026 is calculated as

Total Assets=Total Equity (Q: Jan. 2026 )+Total Liabilities (Q: Jan. 2026 )
=285.167+375.553
=660.7

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of ₹660.7 Mil mean?
Avience Biomedicals (NSE:AVIENCE) has a Total Assets of ₹660.7 Mil as of Jan. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on Avience Biomedicals and its competitors.
Is Avience Biomedicals' Total Assets too high?
Avience Biomedicals' current Total Assets is ₹660.7 Mil. Overall, Avience Biomedicals has a GF Score™ of 5/100, reflecting its overall financial health beyond just this single metric.
How does Avience Biomedicals' Total Assets compare to ABT and SYK?
Avience Biomedicals' Total Assets of ₹660.7 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Medical Devices & Instruments company?
A good Total Assets depends on the Medical Devices & Instruments industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Avience Biomedicals and its competitors. Avience Biomedicals's current Total Assets is ₹660.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avience Biomedicals stock overvalued right now?
Avience Biomedicals (NSE:AVIENCE) has a current Total Assets of ₹660.7 Mil. The current Total Assets is ₹660.7 Mil. Avience Biomedicals' overall GF Score™ is 5/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Avience Biomedicals (NSE:AVIENCE), the current Total Assets is ₹660.7 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Avience Biomedicals Business Description

Address C-11, Block-C, Community Centre, Unit No-2, 1st Floor, Janakpuri A-3, New Delhi, IND, 110058
Avience Biomedicals Ltd is a medical consumables company focused on the manufacturing of Vitro-Diagnostic (IVD) products and medical devices. Its product offerings include diagnostic solutions used for the detection of diseases, conditions, and infections across laboratory, healthcare, and home-use applications. The company operates in areas including molecular biotechnology, genomics, and diagnostic products, and also provides distribution services for medical technology products in India. Its revenue is generated from Manufactured Goods and Traded Goods and Services, which include the sale of Medical Devices and Consumables.
5GF Score

Get the complete analysis for NSE:AVIENCE

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹414.95
Price